128 related articles for article (PubMed ID: 32142761)
1. Comparative metabolism of schaftoside in healthy and calcium oxalate kidney stone rats by UHPLC-Q-TOF-MS/MS method.
Liu R; Meng C; Zhang Z; Ma H; Lv T; Xie S; Liu Y; Wang C
Anal Biochem; 2020 May; 597():113673. PubMed ID: 32142761
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling comparison of isovitexin in normal and kidney stone model rats by ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Meng C; Liu R; Wang W; Guo W; Ma H; Xie S; Liu Y; Wang C
J Sep Sci; 2020 Jun; 43(12):2363-2379. PubMed ID: 32227654
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of a natural product mogroside V, in healthy and type 2 diabetic rats.
Zhou G; Zhang Y; Li Y; Wang M; Li X
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1079():25-33. PubMed ID: 29428672
[TBL] [Abstract][Full Text] [Related]
4. Identification of poliumoside metabolites in rat plasma, urine, bile, and intestinal bacteria with UPLC/Q-TOF-MS.
Qian H; Yu FJ; Lu DY; Wu BJ; Zhang XW; Wang H; Ma ZG
Chin J Nat Med; 2018 Nov; 16(11):871-880. PubMed ID: 30502769
[TBL] [Abstract][Full Text] [Related]
5. Screening for in vitro metabolites of kakkalide and irisolidone in human and rat intestinal bacteria by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Zhang G; Gong T; Kano Y; Yuan D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():117-24. PubMed ID: 24412694
[TBL] [Abstract][Full Text] [Related]
6. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
7. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
8. Systematic Strategy for Metabolites of Amentoflavone
Wang B; Lu Y; Hu X; Feng J; Shen W; Wang R; Wang H
J Agric Food Chem; 2020 Dec; 68(50):14808-14823. PubMed ID: 33322906
[TBL] [Abstract][Full Text] [Related]
9. Animal models of kidney stone formation: an analysis.
Khan SR
World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
[TBL] [Abstract][Full Text] [Related]
10. Identification of urine biomarkers for calcium-oxalate urolithiasis in adults based on UPLC-Q-TOF/MS.
Wang X; Wang M; Ruan J; Zhao S; Xiao J; Tian Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():290-297. PubMed ID: 31255901
[TBL] [Abstract][Full Text] [Related]
11. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of oxalate and citrate in urine and serum of calcium oxalate kidney stone rats by IP-RP LC-MS/MS.
Li W; Zheng J; Chen M; Liu B; Liu Z; Gong L
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123395. PubMed ID: 35940058
[TBL] [Abstract][Full Text] [Related]
13. Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.
Liu Y; Yao X; Song L; Liu H; Zhao Q; Jiang J; Ni G; Shi C; Ma X; Zhou H; Liu D; Hu P
J Pharm Biomed Anal; 2018 Aug; 157():189-200. PubMed ID: 29803910
[TBL] [Abstract][Full Text] [Related]
14. Study on Fu-Fang-Jin-Qian-Cao Inhibiting Autophagy in Calcium Oxalate-induced Renal Injury by UHPLC/Q-TOF-MS-based Metabonomics and Network Pharmacology Approaches.
Liu WR; Li MT; Zhou Q; Gao SY; Hou JB; Yang GB; Liu NM; Jia-Yan ; Yu JP; Cheng J; Guo ZY
Comb Chem High Throughput Screen; 2024; 27(1):90-100. PubMed ID: 37190798
[TBL] [Abstract][Full Text] [Related]
15. Identification and Pharmacokinetic Studies on Complanatuside and Its Major Metabolites in Rats by UHPLC-Q-TOF-MS/MS and LC-MS/MS.
Yao YF; Lin CZ; Liu FL; Zhang RJ; Zhang QY; Huang T; Zou YS; Wang MQ; Zhu CC
Molecules; 2018 Dec; 24(1):. PubMed ID: 30585251
[TBL] [Abstract][Full Text] [Related]
16. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
[TBL] [Abstract][Full Text] [Related]
17. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
18. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
[TBL] [Abstract][Full Text] [Related]
19. UPLC-Q-TOF/MS-based metabolic profiling comparison of four major bioactive components in normal and CKD rat plasma, urine and feces following oral administration of Cornus officinalis Sieb and Rehmannia glutinosa Libosch herb couple extract.
Tao JH; Zhao M; Jiang S; Zhang W; Xu BH; Duan JA
J Pharm Biomed Anal; 2018 Nov; 161():254-261. PubMed ID: 30172880
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic analysis reveals a protective effect of Fu-Fang-Jin-Qian-Chao herbal granules on oxalate-induced kidney injury.
Chen W; Liu WR; Hou JB; Ding JR; Peng ZJ; Gao SY; Dong X; Ma JH; Lin QS; Lu JR; Guo ZY
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30737304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
